Hamamelis

Selected form

-

Method of action: Adaptogenic, Adrenolytic, Adsorbing, Alpha-Adrenomimetic, Ample Deficiency, Analgesic, Analgetic, Androgenic, Angioprotective, Anorexigenic

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hamamelis

This section provides a foundational overview of Hamamelis (Witch hazel), covering its identity, composition, and general purpose as a medicinal product.

Property	Description
Active ingredient	Tannins (Hamamelitannin), Flavonoids
Forms	Fluid extracts, Steam distillates (Hamamelis Water), Ointments, Creams
Pharmacological class	Astringent active ingredient, Phytopharmaceutical
Common use	Relief of minor skin irritations and surface discomfort
Origin	Hamamelis virginiana L. (North American deciduous shrub)

What is Hamamelis and Where Does it Come From?

Hamamelis is an herbal drug or phytopharmaceutical product derived from the dried leaves (Hamamelidis folium) and bark (Hamamelidis cortex) of the deciduous shrub Hamamelis virginiana L., commonly known as Witch hazel. This entity is a natural, plant-based medicine native to Eastern North America and is utilized globally in various topical and rectal pharmaceutical preparations. The use of Hamamelis as an official herbal drug is supported by scientific monographs.

What Type of Medicine is Hamamelis?

Hamamelis belongs to the pharmacological class of astringent active ingredients, a function intrinsically linked to its primary components: tannins. The active ingredients include hydrolysable and condensed tannins, such as Hamamelitannin, along with flavonoids and volatile oil components. It is classified as an over-the-counter topical skin protectant. Preparation methods lead to significant variation: fluid extracts are rich in tannins and highly astringent, while the steam distillate (Hamamelis Water) contains minimal tannins, consisting mainly of water and alcohol (ethanol).

What is the General Purpose of Hamamelis?

The general purpose of Hamamelis is to provide soothing and surface protection for minor skin irritations by leveraging the effect of astringency. This effect is achieved when the tannins bind to proteins, causing the tissue surface to contract and firm. Hamamelis preparations are characterized by antioxidant and anti-inflammatory properties through this mechanism. The active components contribute to reducing local oxidative stress and inflammation. This local vasoconstrictive and antimicrobial action helps to reduce minor swelling and creates a protective barrier, which aids the toning and firming of irritated tissues, such as when providing relief for a minor scrape or sunburn.

What side effects are possible with Hamamelis?

Possible Side Effects and Safety Information

The official safety profile for Hamamelis, commonly known as Witch hazel, is primarily defined by documented adverse reactions affecting the skin and specific constraints related to usage in vulnerable populations. As defined by regulatory agencies, the most clinically relevant adverse reaction is the potential for allergic contact dermatitis.

Adverse Reactions and Classification

The adverse effects reported in official documentation are chiefly associated with the Skin and Subcutaneous Tissue Disorders (dermatological system). These include local skin irritation and allergic skin reactions. While allergic contact dermatitis has been reported, the precise frequency is often classified as Not Known in traditional medicine regulatory monographs due to limitations in data for exact classification. Individuals with a known hypersensitivity to Hamamelis or any of its components are contraindicated from use.

Population-Specific Safety Considerations

The official safety information highlights significant data gaps for specific populations. The use of Hamamelis preparations is not recommended during pregnancy or lactation because sufficient data to establish safety in these periods are unavailable. Similarly, the safety of Hamamelis use is not established for children under 12 years of age for cutaneous preparations or under 18 years for rectal preparations, leading to official recommendations against its use in these age groups unless otherwise specified by a regulatory body.

Safety Structure Summary

The medicine's regulatory safety structure is built upon the documented risk of allergic reactions and the formal acknowledgement of insufficient safety data for pediatric, pregnant, and lactating populations. High-tannin preparations are generally restricted to external use, which is a high-level safety constraint.

Overdose and Emergency Response

Overdose and when to seek help

Regulatory bodies confirm that, based on available clinical data, no cases of overdose have been formally documented following the approved topical or rectal use of Hamamelis preparations. The official regulatory profile for this product focuses instead on the mandatory emergency actions required after accidental exposure, particularly if a product intended solely for external application is swallowed.

Required Emergency Actions

If any Hamamelis preparation intended for external use is accidentally ingested, immediate medical attention must be sought. Government guidance mandates calling a Poison Control Centre or seeking medical help right away. This urgent action is required because the concentrated extracts contain high levels of tannins, and accidental oral exposure may potentially affect the gastrointestinal system (e.g., stomach upset) or the hepatic system (e.g., liver problems).

Population-Specific Note and Management

It is a specific regulatory instruction that if a child accidentally swallows the product, emergency medical services must be contacted immediately for evaluation. In the event of exposure requiring intervention, the management approach officially described is symptomatic and supportive. No specific antidote is stated in the current regulatory prescribing information. Clinical monitoring for adverse effects may be warranted following ingestion, as potential symptoms may evolve over time.

Therapeutic Uses of Hamamelis

What Hamamelis Treats: Main Uses and Benefits

Hamamelis preparations have traditional use for the symptomatic relief of itching and burning associated with hemorrhoids and for the relief of minor skin inflammation and dryness.

Hamamelis is commonly used in situations involving certain distressing symptoms across domains involving minor dermatological inflammation and anorectal irritation. It is relevant for easing local symptoms, primarily itching and burning, and is used in conditions like minor cuts, diaper rash, and mild sunburn. Its use generally provides support that helps ease the overall symptom burden during periods of heightened symptoms.

Quick Facts: Symptom Management

Relief for Discomfort: Supports easing local symptoms associated with hemorrhoids and minor skin irritation.
Supportive Use: Applied for managing symptoms linked to temporary surface distress, such as mild swelling and redness (erythema).
Skin Toning: Is commonly used to help with symptomatic relief and supportive management of oily skin and minor surface blemishes.

Regulatory References

EMA therapeutic overview of Hamamelis

Eligibility and Restrictions for Use

The eligibility for using Hamamelis (Witch hazel) preparations is defined by regulatory bodies based on age, formulation, and specific health states, with restrictions often cited due to a lack of established data.

Official Eligibility Classifications

Classification	Population/Condition
Contraindicated	Individuals with known hypersensitivity to Hamamelis virginiana or product excipients.
Not Recommended	Pregnant and lactating women (due to insufficient safety data).
Not Recommended	Children under 12 years of age for most concentrated extracts/tinctures.
Conditional Use	Patients experiencing rectal bleeding must consult a doctor before use.

Use is generally established for adults and older adults for labeled topical and anorectal uses. Regulatory labels state that the use of extracts and tinctures is not recommended in children under 12 and rectal preparations are not recommended for those under 18 because safety has not been established in these populations. For all users, persistent symptoms require medical consultation.

What should I know about interactions with other medicines?

Interactions with other medicines and products for Hamamelis

Official regulatory information for topical Hamamelis (Witch hazel) preparations focuses primarily on local physical interactions at the site of administration, as its active components have minimal to no systemic absorption.

Interaction Scope

Category	Official Regulatory Information
Interacting substance categories	Other topical medicinal products (creams, ointments, lotions)
Mechanistic basis of interactions	Local Physical Interference (e.g., binding and protein precipitation by tannins, leading to reduced local availability).
Timing-based interaction rules	Mandatory temporal separation of administration from other topical products.
Population-specific notes	None documented based on formal interaction studies.

Resulting Interaction Structure

Official interaction statements:

Co-administration of Hamamelis preparations with other topical medicinal products applied to the same area is subject to local physical interference.
The astringent property derived from tannins may physically reduce the local absorption or availability of other substances applied concurrently.
Due to this local interference, Hamamelis must not be applied simultaneously with other topical medicines.
Certain liquid preparations (steam distillates) contain ethanol (alcohol) as a formulation component, which carries an excipient-based interaction risk with alcohol-sensitive topical agents.

Connection to the overall interaction profile:

Regulatory documents define the product's interaction structure around its topical route of administration and the local physical action of its components. The formal interaction information is limited to constraints requiring mandatory timing separation from other topical agents and notes on excipient-based risks.

Mechanism of Action

The mechanism of action for Hamamelis extracts is a localized, dual-action process driven primarily by its tannins and flavonoids. The immediate effect is astringency, a physical-chemical cascade initiated by tannins binding rapidly to surface proteins on epithelial and vascular tissues. This binding induces protein precipitation and cross-linking, causing tissue contraction and localized micro-vasoconstriction. This physiological change restricts the outward leakage of fluid from capillaries, contributing to localized adjustments in fluid kinetics and tissue structural integrity. The secondary, cellular action involves the polyphenols acting as modulators of inflammatory pathways. They operate by inhibiting enzymes, such as 5-Lipoxygenase (5-LOX), and impairing transcription factors like NF-κB. By intervening in these signaling cascades, the mechanism reduces the cell's ability to synthesize and release specific mediators, including leukotrienes and certain cytokines. This action contributes to the modulation of the local inflammatory cascade. The complete activity is highly dependent on component concentration; for instance, steam distillates, which lack significant tannin content, exhibit an attenuated mechanism of action.

Dosage and Administration Information

Instruction Map: How to use Hamamelis — Official Administration Guidelines

Administration of Hamamelis preparations is predominantly local, directed at surface application. Usage principles are based on recognized medicinal standards which specify the administration route, frequency, and duration of use.

Administration Scope

Parameter	Instruction Details (Strictly Label-Based)
Route of administration	Primarily Topical/Cutaneous, Anorectal (for suppositories and ointments), and Oromucosal (gargle/mouthwash).
Dosing schedule	Topical semi-solid preparations (e.g., 1.3% dry extract ointment) are applied to the affected area. Anorectal suppositories may contain a fixed dose, such as 66 mg of dry extract per unit.
Timing in relation to meals	For oral use of dried extracts (as sanctioned in some regions), administration should occur a few hours before or after the intake of minerals or B-vitamin supplements.
Preparation requirements	Tinctures intended for oromucosal application must be diluted with water prior to use. Comminuted herbal substance requires preparation as a decoction for use as compresses or rinses.
Age-group administration rules	The use of Hamamelis preparations is not recommended for children under 12 years of age. Anorectal preparations are not recommended for adolescents under 18 years.
Special procedural conditions	The maximum period for self-administration of topical and oromucosal preparations is typically limited to 1 week.

Resulting Procedural Structure

Official step sequence:

The appropriate dosage form is selected based on the route (e.g., semi-solid for cutaneous, diluted liquid for oromucosal).
The preparation is administered several times daily to the localized area of application, such as applying a topical liquid that may contain 0.1% to 2.5% Hamamelis extract.
Use is discontinued if the symptoms being addressed persist after the specified 1-week duration of self-care.

Connection to the overall use protocol (2–4 sentences): The official instructions establish a structured protocol where the medicine is administered locally on a multiple-times-daily schedule for direct surface action. This frequent application pattern is constrained by a clear time limit of 1 week for self-treatment, and specific preparation steps such as dilution are mandated to ensure the product is used correctly as specified in professional medicinal standards.

Recent Clinical Evidence

Research evidence / Overview of studies for Hamamelis

Evidence for Use in Symptomatic Relief of Hemorrhoids

Research was studied for Hamamelis preparations in conditions characterized by fluctuating or episodic manifestations, such as itching and burning. Studies were conducted in observational settings evaluating daily-life functioning and open-label clinical studies that included adults with mild to moderate hemorrhoidal symptoms. The research examined changes in local symptoms, primarily tracking changes in individual symptoms and overall patient-reported experiences over defined time intervals. Studies monitored changes measured during short-term treatment durations, typically lasting up to approximately two weeks. One non-interventional study monitored changes tracked by a composite symptom score. The overall evidence is generally considered Moderate and is consistent with its status as a traditional herbal medicine. Follow-up durations were limited, and large-scale, placebo-controlled trials focusing solely on Hamamelis are sparse.

Evidence for Use in Minor Skin Inflammation and Irritation

Research has examined Hamamelis in the context of minor conditions linked to inflammatory or irritative states of the skin. The body of evidence features controlled human volunteer studies where researchers examined specific objective markers, such as measured skin redness (erythema), and patient-reported outcomes describing perceived discomfort. Some comparative trials monitored changes in symptom scores. Research highlights changes measured during the study period, which included application periods ranging from a single instance up to four weeks. Data show patterns related to the specific preparation, such as whether a tannin-rich extract or a tannin-minimal distillate was studied for use.

What is Still Uncertain About Hamamelis Research

Evidence quality varies across studies. A key limitation is the modest sample sizes found in much of the available clinical research, and the reliance on open-label or observational designs for certain indications. Certainty remains low for some uses due to conflicting findings reported in older randomized controlled trials. The scientific literature and regulatory bodies highlight that the evidence for some applications is largely supported by its history of use, rather than by a large volume of high-quality Randomized Controlled Trials (RCTs). Long-term effects are not fully established, and certainty regarding the clinical relevance of certain formulations remains low.

Frequently Asked Questions (FAQ)

Common questions about Hamamelis (FAQ)

Q: How should I store my Hamamelis product to maintain its quality?

Official regulatory documents indicate that Hamamelis preparations should be stored at room temperature and kept away from direct sunlight or excessive heat. Product labels indicate the container should be kept tightly closed when not in use to help prevent quality deterioration. Official labeling also requires the product be kept out of the reach of children.

Q: Can I use a Hamamelis topical cream at the same time as my prescription steroid cream?

Regulatory product information specifies that Hamamelis must not be applied simultaneously with other topical medicinal products, including prescription creams, on the same area of skin. This separation is necessary because of the potential for local physical interference. The astringent components of Hamamelis may reduce how well or how much the other medicine can be absorbed locally.

Q: Are there any known drug interactions when taking Hamamelis orally with supplements?

Official administration instructions note a precaution regarding oral use of certain Hamamelis preparations. They should be taken a few hours before or after consuming mineral and/or B-vitamin supplements. This timing instruction is specified on the regulatory label. Formal interaction studies for oral Hamamelis with other prescription drugs are not consistently detailed in regulatory information.

Q: What is the difference between Witch hazel (Hamamelis Water) and a Hamamelis extract?

The difference lies in the composition and strength. A Hamamelis extract is rich in tannins and highly astringent. In contrast, the steam distillate (commonly called Witch hazel Water or Hamamelis Water) contains only minimal amounts of tannins, consisting mainly of water and alcohol (ethanol). This difference means the water has a much weaker, or attenuated, effect compared to a tannin-rich extract.

Q: What should I do if I accidentally swallow Hamamelis?

Official labeling states that if the Hamamelis product is swallowed, individuals should seek medical help or contact a Poison Control Center right away. This safety statement is mandated for inclusion on the product label.

How should Hamamelis be stored and disposed of?

Storage and Disposal Conditions for Hamamelis Drug Products

Official regulatory labeling dictates specific conditions for storing Hamamelis products to maintain product quality and safety.

Required Storage and Handling

Category	Regulatory Instructions
Temperature and Light	Store at room temperature and keep away from direct sunlight or excessive heat.
Container Integrity	The container must be kept tightly closed when not in use to prevent quality deterioration.
Child Safety	It is mandatory to keep out of reach of children or infants at all times.

Disposal Guidelines

Unused or expired product must be disposed of in accordance with local/regional/national regulations for household drug waste. If the product is swallowed, individuals must get medical help, or contact a Poison Control Center right away, as stated on the regulatory label.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Russia

A-Z Index:

A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z